Acta Scientific Pharmaceutical Sciences (ISSN: 2581-883X)

Short Communication Volume 4 Issue 6

Repurposing Drugs for Covid-19

Amol Bhosale*

Department of Pharmaceutical Sciences, India

*Corresponding Author: Amol Bhosale, Department of Pharmaceutical Sciences, India.

Received: April 19, 2020; Published: June 01, 2020


Coronavirus disease (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2). COVID-19 is the next generation of the SARS-CoV virus. It have a zoonotic origin. coronavirus genetically clusters with genus Betacoronavirus, in subgenus Sarbecovirus. Common symptoms include fever, cough and shortness of breathing. In this condition, there are urgent for an effective treatment to treat COVID-19 infection.



Citation: Amol Bhosale. “Repurposing Drugs for Covid-19".Acta Scientific Pharmaceutical Sciences 4.6 (2020): 26.


Acceptance rate33%
Acceptance to publication20-30 days
Impact Factor1.197

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is June 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US